Profil
Shana O.
Kelley is the founder of Xagenic, Inc. (founded in 2010) and holds the title of Chief Executive Officer & Director.
Dr. Kelley is also the founder of GeneOhm Sciences, Inc., CTRL Therapeutics, Inc...
Dr. Kelley's current job is as a Board of Director at The Canadian Academy of Health Sciences since 2017.
Dr. Kelley's former jobs include being a Board of Director at Ontario Genomics Institute (Private Equity) from 2016 to 2020 and a Board of Director at Fight Against Cancer Innovation Trust.
Dr. Kelley's education includes a doctorate degree from California Institute of Technology in 1999 and an undergraduate degree from Seton Hall University in 1994.
Aktive Positionen von Shana Kelley
Unternehmen | Position | Beginn |
---|---|---|
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | Gründer | 01.01.2010 |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Gründer | - |
The Canadian Academy of Health Sciences | Direktor/Vorstandsmitglied | 01.09.2017 |
Ehemalige bekannte Positionen von Shana Kelley
Unternehmen | Position | Ende |
---|---|---|
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Direktor/Vorstandsmitglied | 01.01.2020 |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Gründer | - |
Ausbildung von Shana Kelley
California Institute of Technology | Doctorate Degree |
Seton Hall University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | Health Technology |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Finance |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
The Canadian Academy of Health Sciences |